Blechingley Tunnel sick fund.—The late Mr. Rennie's Report upon the Highgate Archway Tunnel

2015 ◽  
pp. 169-175
Author(s):  
Frederick Walter Simms
Keyword(s):  
1972 ◽  
Vol 121 (565) ◽  
pp. 635-639 ◽  
Author(s):  
Y. Fried ◽  
F. Brüll

The psychiatric services in the field of community psychiatry in Israel have developed in a number of directions over the past decade. Following the establishment by the Workers' Sick Fund (Kupat Holim) of a Rehabilitation Unit for chronic psychiatric patients (Wijsenbeek and Lindner (53)) and the opening of a Day Hospital for acute cases in conjunction with a psychiatric hospital (Ramot and Jaffe (45)), a Day Hospital was established in October 1968, at the Out-Patient Mental Health Clinic (Ramat Chen), to serve acute psychiatric patients. This represented the first attempt of its kind in Israel. The professional literature on Day Hospitals, which in the main describes a ‘half-way out’ type of hospital (Farndale (16); Epps and Hanes (14); Kramer (32)), also reports the existence of a ‘half-way in’ type of institution, operating as an autonomous service catering to a particular geographical region, without being attached directly to a mental hospital. This kind of Day Hospital, specifically designed for acute cases, has not yet been tried in Israel.


1995 ◽  
Vol 5 (1) ◽  
pp. 3-5
Author(s):  
John Hess

BEFORE GOING INTO THE SPECIFIC AREAS OF PEDIATRIC cardiology and pediatric cardiac cardiology and pediatric cardiac surgery, an overview of the general health care organization in the Netherlands might be helpful. The Netherlands, a country with about 15 million inhabitants, spent 47 billion Dutch guilders (US$22 billion) for general health care in 1991. This is about 8.5% of the gross domestic product. Of this, 61% was spent on in-hospital costs, 39% on extramural costs, including the financing of organizations that deal with preventive (primary) medicine, such as clinics for infants and school children which were visited regularly. Almost all inhabitants, 99.6%, are covered for the expenses of health care, 60% through the “Sick Fund,” a state-insurance that is obliged for everyone with a yearly income of less than US$30,000. Employers of these people have to deduct an amount of money from the monthly salary to be paid to the “Sick Fund.” In case of unemployment this money is deducted from the amount paid by the social security office. The remaining 40% has some form of private insurance, that covers health care. Both diagnostic and therapeutic approaches as the timing of these are completely similar and independent from the type of insurance that applies for the individual patient.


1961 ◽  
Vol 59 (1) ◽  
pp. 123-132 ◽  
Author(s):  
A. Michael Davies ◽  
A. Suchowolski

1. The incidence of infectious hepatitis calculated from official notifications fluctuated between 5·7 and 11·4 per 10,000 during the years 1949–57, while reports of the Workers' Sick Fund indicated a rate three to four times greater. The highest rates were between the ages 1 and 9, two-thirds of the cases being under 10. Mortality was very low.2. Highest attack rates were seen under conditions of crowding, i.e. in agricultural schools, communal settlements and new immigrant towns. This fact, together with the winter peak of incidence, suggests a contact-respiratory form of spread.3. Immigrants, regardless of country, showed particular susceptibility during their first year or two in Israel. In the long run there was no difference in attack rate between immigrants from Western and from Middle Eastern countries, in spite of the known endemicity of the disease in the Middle East. In communities such as those from Yemen and North Africa, with large families and with, on the whole, a lower economic status, the mean age at onset was significantly younger. Among the non-Jewish population, the incidence was lower than expected due partly to under-reporting and partly, perhaps, to a mild form of the disease in the very young.


2019 ◽  
Vol 36 ◽  
pp. 101396 ◽  
Author(s):  
Detournay Bruno ◽  
Debouverie Marc ◽  
Pereira Ouarda ◽  
Seyer Dominique ◽  
Soudant Marc ◽  
...  

1996 ◽  
Vol 10 (1) ◽  
pp. 67-80
Author(s):  
Revital Gross ◽  
Bruce Rosen
Keyword(s):  

2019 ◽  
Vol 35 (S1) ◽  
pp. 87-87
Author(s):  
Aljoscha Neubauer ◽  
Susanne Guthoff-Hagen ◽  
Jacob Menzler ◽  
Carsten Schwenke ◽  
Markus Rueckert ◽  
...  

IntroductionIn rare disease areas representative data are scarce. Routine sick fund claims data provide a meaningful and reliable base for the in- and outpatient treatment landscape. This real-world data (RWE) from Germany was used to describe treatment patterns for Diffuse Large B-cell Lymphoma (DLBCL), the most frequent and aggressive non-Hodgkin lymphoma type in adults.MethodsClaims data from several sick funds of 4.8 Million insured were analyzed. Diagnosis of non-follicular Lymphoma (C83) was confirmed in 2.178 patients, DLBCL (C83.3) in 819 patients. The analysis was age- and gender-adjusted, observational period was 2014 and 2015. Treatments were analyzed for hospitalization and medication based on ATC-Code, Pharma Central Number and coded diagnoses (per ICD).ResultsMean age of DLBCL patients was 60.3 years, with two peaks at 50-54 and 70-74 years. Total costs for patients with DLBCL averaged 25.048 EUR versus 1.259 EUR in healthy insured. Charlson comorbidity index (CCI) of 4.58 indicates clinical relevance and severity. Comorbidities included several psychiatric diagnoses such as depression in every fifth patient. Mean 3.2 hospitalizations with average 31.5 hospital days were observed in DLBCL patients. Forty-seven percent of patients during observational time-frame did not receive oncological treatment, including relapsed / refractory patients. Only few patients received stem cell transplantation (2.6 percent) or radiation (3.9 percent). Most pharmacological treatments were Rituximab (RTX) + CHOP (57 percent), followed by RTX mono therapy (25 percent) or RTX in combination with Bendamustine (8 percent).ConclusionsDespite limitations in sick fund claims analyses, these provide a reasonable database for rare diseases. They allow standard treatment pathway- and longitudinal analyses. All DLBCL patients frequently required hospitalization and generated significant costs. A high unmet medical need exists for treatments other than palliative care, especially for a tolerable and effective outpatient therapy in elderly relapsed / refractory DLBCL.


Sign in / Sign up

Export Citation Format

Share Document